Baxter International Inc (BAX)
33.22
+0.22
(+0.68%)
USD |
NYSE |
Nov 22, 16:00
33.12
-0.10
(-0.29%)
After-Hours: 20:00
Baxter International Research and Development Expense (Quarterly): 129.00M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 129.00M |
| June 30, 2024 | 173.00M |
| March 31, 2024 | 176.00M |
| December 31, 2023 | 276.00M |
| September 30, 2023 | 133.00M |
| June 30, 2023 | 165.00M |
| March 31, 2023 | 164.00M |
| December 31, 2022 | 154.00M |
| September 30, 2022 | 151.00M |
| June 30, 2022 | 148.00M |
| March 31, 2022 | 150.00M |
| December 31, 2021 | 135.00M |
| September 30, 2021 | 129.00M |
| June 30, 2021 | 139.00M |
| March 31, 2021 | 128.00M |
| December 31, 2020 | 135.00M |
| September 30, 2020 | 123.00M |
| June 30, 2020 | 117.00M |
| March 31, 2020 | 146.00M |
| December 31, 2019 | 156.00M |
| September 30, 2019 | 144.00M |
| June 30, 2019 | 166.00M |
| March 31, 2019 | 129.00M |
| December 31, 2018 | 175.00M |
| September 30, 2018 | 166.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 174.00M |
| March 31, 2018 | 140.00M |
| December 31, 2017 | 183.00M |
| September 30, 2017 | 150.00M |
| June 30, 2017 | 155.00M |
| March 31, 2017 | 127.00M |
| December 31, 2016 | 156.00M |
| September 30, 2016 | 159.00M |
| June 30, 2016 | 195.00M |
| March 31, 2016 | 136.00M |
| December 31, 2015 | 161.00M |
| September 30, 2015 | 148.00M |
| June 30, 2015 | 151.00M |
| March 31, 2015 | 143.00M |
| December 31, 2014 | 156.00M |
| September 30, 2014 | 149.00M |
| June 30, 2014 | 322.00M |
| March 31, 2014 | 309.00M |
| December 31, 2013 | -187.00M |
| September 30, 2013 | 277.00M |
| June 30, 2013 | 273.00M |
| March 31, 2013 | 246.00M |
| December 31, 2012 | 216.00M |
| September 30, 2012 | 290.00M |
| June 30, 2012 | 306.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
117.00M
Minimum
Jun 2020
276.00M
Maximum
Dec 2023
151.35M
Average
147.00M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 407.00M |
| Haemonetics Corp | 16.53M |
| Accuray Inc | 12.12M |
| Masimo Corp | 48.30M |
| Insulet Corp | 54.90M |